Synageva BioPharma Adds $12 Million

Synageva BioPharma Corp., a Waltham, Mass.-based developer of protein therapeutics, has raised $12 million in new six-thround funding, bringing the round total to $45 million. New Leaf Venture Partners joined existing backers Hunt BioVentures, Yasuda Enterprise Development, Baker Brothers Investments, Tullis Dickerson and Four Partners. The company has now raised around $95 million.

North AmericaUSBriefs